Zobrazeno 1 - 10
of 40
pro vyhledávání: '"A. F. Kalashnikova"'
Autor:
N. V. Likhodey, V. E. Epishin, M. F. Kalashnikova, A. M. Kaurova, M. V. Tulupova, Y. P. Sych, I. B. Bondareva
Publikováno v:
Сахарный диабет, Vol 27, Iss 5, Pp 429-440 (2024)
BACKGROUND: Diabetes distress (DD) is the negative emotional or affective experience resulting from living with diabetes. DD is a negative predictor of blood glucose control and quality of life, and may lead to decreased adherence to treatment. To di
Externí odkaz:
https://doaj.org/article/c3f6a3b3a1e3483bba5e94dc1142a5ec
Autor:
Ilya I. Amergoolov, Yulia I. Khruleva, Maria G. Pavlova, Natalia V. Likhodey, Abu M. Sulaev, Elena V. Surkova, Yulia P. Sych, Marina F. Kalashnikova, Anna S. Arustamyan, Gratsinna A. Martirosyan, Simione T. Lew-Gor
Publikováno v:
European Journal of Translational Myology (2024)
Kearns-Sayre Syndrome (KSS) is a variant of mitochondrial disorder caused by a Mitochondrial Deoxyribonucleic Acid (mtDNA) deletion. Clinical manifestations of KSS can include different organ and system involvement. Different organ malfunctions, more
Externí odkaz:
https://doaj.org/article/6eee8dea7bae4ea29c63fa74e4da5bb2
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 427-438 (2023)
BACKGROUND: When developing programs for state reimbursement of the cost of medical services and medicines, when providing assistance to patients suffering from type 1 diabetes mellitus (DM1), data based on the results of pharmacoepide-miological stu
Externí odkaz:
https://doaj.org/article/6b53283e0f8142889de9771298e89d7b
Autor:
E. S. Maloletkina, O. Y. Gurova, I. V. Glinkina, M. V. Amosova, Zh. Zh. Shyman, I. A. Khaykina, M. F. Kalashnikova, V. V. Fadeev
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 62-74 (2022)
Introduction. In type 2 diabetes mellitus, an inevitable decrease in the secretion of β-cells of the pancreas occurs, which requires the initiation of insulin therapy. Currently, there have been no studies evaluating the features of insulin therapy
Externí odkaz:
https://doaj.org/article/2248908a5261466c994a5241f16d31fa
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 7, Pp 476-486 (2020)
Background: Low treatment adherence in patients with type 2 diabetes mellitus (T2DM) hinders the effective use of anti-diabetic agents and the achievement of glycemic control, reducing their quality of life and outcomes. Assessment of treatment adher
Externí odkaz:
https://doaj.org/article/c5e57626734141fb94aae755aaf5679f
Autor:
Mikhail B. Antsiferov, Nikolay A. Demidov, Marina F. Kalashnikova, Olga V. Duhareva, Olga K. Vikulova, Marina V. Shestakova
Publikováno v:
Сахарный диабет, Vol 23, Iss 2, Pp 113-124 (2020)
BACKGROUND: State Register of Diabetes Mellitus (SRDM) plays an important role in the dynamic analysis of the epidemiological parameters that evaluate the disease itself and its complications, and also helps to analyze the quality of specialized medi
Externí odkaz:
https://doaj.org/article/aa0cc1c6ed4c40c3ab8d908ce68b3a5f
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 27-52 (2019)
The aim. Based on a pharmacoeconomic analysis (PHe) of the use of sodium-glucose cotransporter-2 inhibitors (iSGLT2) and dipeptidyl peptidase-4 (iDPP-4) inhibitors to determine the optimal treatment strategy in patients with type 2 diabetes mellitus
Externí odkaz:
https://doaj.org/article/72c15650399c4fb8819759b378de1f25
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 3, Pp 4-16 (2018)
Objectives. To evaluate the cost-effectiveness of dapagliflozin in combination with metformin in the treatment T2DM in comparison with glimepiride and sitagliptin also combined with metformin. Methods. Cost-utility analysis, discounting and economic
Externí odkaz:
https://doaj.org/article/d339c1b55623436bafa6bd24b4196587
Publikováno v:
Сахарный диабет, Vol 21, Iss 1, Pp 5-14 (2018)
This review examined the current problem of low adherence to treatment in patients with chronic diseases, particularly type 2 diabetes mellitus. According to the definition of the World Health Organization, ‘adherence to treatment’ is the degree
Externí odkaz:
https://doaj.org/article/724422fd3dc147fc8691a8c50916964f
Autor:
Ivan I. Dedov, Marina F. Kalashnikova, Dmitriy Y. Belousov, Aleksey S. Kolbin, Vladimir V. Rafalskiy, Aleksey E. Cheberda, Mariya A. Kantemirova, Vadim D. Zakiev, Valentin V. Fadeyev
Publikováno v:
Сахарный диабет, Vol 20, Iss 6, Pp 403-419 (2017)
Background: Cost-of-Illness Analysis (COI) constitutes the basis for the decision-making process on the budget and allocation in a modern health care system. Considering the wide prevalence of type 2 diabetes mellitus (Т2DM), it is important to perf
Externí odkaz:
https://doaj.org/article/539c7cdef59a4e00acef6e429a6d993f